Crosslink Capital led round, advancing Phil’s disruption of traditional prescription management.
SAN FRANCISCO–(BUSINESS WIRE)–Phil Inc., an end-to-end prescription management and delivery service connecting patients with local pharmacies, announced today its national expansion following its recent $10M funding round close led by Crosslink Capital. Other investors include Eniac Ventures, Softtech VC, Forerunner Ventures, SV Angel, Silicon Valley Bank, and Transmedia Capital. Top-rated, independent pharmacies in all major states are now part of Phil’s fast-growing network, which since November 2016 has grown to cover 95 percent of the U.S. population.
Phil’s alternative to traditional pharmaceutical management aims to solve the problem of drug adherence, which drives between $100B and $300B in unnecessary medical costs in the U.S. each year. Read rest here.